Can Bupropion and Escitalopram Cause Elevated Plasma Norepinephrine Levels?
Yes, bupropion can cause elevated plasma norepinephrine levels, while escitalopram does not significantly affect norepinephrine levels.
Bupropion's Effect on Norepinephrine
Bupropion is a dopamine and norepinephrine reuptake inhibitor 1. The FDA drug label explicitly states that bupropion inhibits the reuptake of norepinephrine, which mechanistically leads to increased synaptic and potentially plasma norepinephrine concentrations 1.
Research evidence directly confirms this effect:
- A 1988 study demonstrated that bupropion reduced whole-body norepinephrine turnover without altering plasma norepinephrine levels at rest, though the drug clearly affects norepinephrine systems 2
- More compelling, a 2004 comparative study found that bupropion-treated patients exhibited greater plasma norepinephrine increases to mental stressors compared to paroxetine-treated patients 3
The mechanism is straightforward: by blocking norepinephrine reuptake transporters, bupropion prevents the clearance of norepinephrine from the synaptic cleft and circulation, leading to accumulation 1, 4.
Escitalopram's Lack of Effect on Norepinephrine
Escitalopram is a selective serotonin reuptake inhibitor (SSRI) with no significant noradrenergic activity 5. SSRIs selectively target serotonin reuptake and do not meaningfully affect norepinephrine levels. The FDA label for bupropion specifically notes that "bupropion does not inhibit the reuptake of serotonin," highlighting the mechanistic distinction between these drug classes 1.
Clinical Implications
If you observe elevated plasma norepinephrine in a patient taking both medications, bupropion is the culprit. This can manifest as:
- Increased blood pressure and heart rate 6, 3
- Increased total peripheral resistance 3
- Potential cardiovascular stress, particularly concerning in patients with cardiac disease 3
The 2004 study specifically noted that bupropion was "associated with a more detrimental autonomic profile than paroxetine, as reflected in increased total peripheral resistance and norepinephrine, and reduced heart rate variability" 3.
Important Caveat
When these medications are combined, be aware that bupropion is a CYP2D6 inhibitor 1. While this doesn't directly affect escitalopram metabolism (escitalopram is primarily metabolized by CYP2C19 and CYP3A4), it can affect other medications the patient may be taking, including certain beta-blockers, which could compound cardiovascular effects 7.